Protea Biosciences Group, Inc. (OTCMKTS:PRGB) Files An 8-K Other Events
Item 8.01Other Events.

On March 2, 2017, Protea Biosciences Group, Inc., (the “Company”) filed with the Securities and Exchange Commission a definitive schedule 14A consent solicitation statement (the “Consent Solicitation”) and thereafter mailed the Consent Solicitation to all Company stockholders as of February 21, 2017 (the “Record Date”). Under the Consent Solicitation, as filed with the Securities and Exchange Commission, the Company expressly reversed the right, as determined in its sole discretion, to extend the deadline to receive written consents from Company shareholders, as of the Record Date.

On March 30, 2017 the Company’s board of directors approved the Company’s decision to exercise such discretionary right by extending the deadline to receive written consents under the Consent Solicitation from the original date of March 30, 2017 to the revised date of April 28, 2017.

About Protea Biosciences Group, Inc. (OTCMKTS:PRGB)

Protea Biosciences Group, Inc. is a molecular information company. The Company is engaged in developing and commercializing life science technologies, products and services to identify the molecules that are produced by living cells and all life forms. It also offers a platform technology, Laser Ablation Electrospray Ionization (LAESI), which enables the direct analysis, mapping and display of molecular information in living cells and tissue samples. The Company’s commercial development is centered in three business lines: Molecular Information Services, LAESI Instruments, Software and Consumables, and Molecular Diagnostics and Clinical Research. Its services enable the identification and quantitation of both small molecules (lipids and metabolites) and large molecules (proteins) and the services portfolio, inclusive of mass spectrometry imaging (MSI), proteomics, metabolomics, lipidomics and bioinformatics. Its clients include pharmaceutical, chemical and biotechnology companies.

Protea Biosciences Group, Inc. (OTCMKTS:PRGB) Recent Trading Information

Protea Biosciences Group, Inc. (OTCMKTS:PRGB) closed its last trading session 00.0000 at 0.0800 with 141,200 shares trading hands.